BioXcel Therapeutics
BTAI
#9512
Rank
โ‚ฌ24.78 M
Marketcap
0,61ย โ‚ฌ
Share price
3.12%
Change (1 day)
-86.37%
Change (1 year)

EPS for BioXcel Therapeutics (BTAI)

EPS in 2023 (TTM): -6,70ย โ‚ฌ

According to BioXcel Therapeutics's latest financial reports the company's current EPS (TTM) is -6,50ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -5,41ย โ‚ฌ a decrease over its 2021 EPS that were of -3,73ย โ‚ฌ.

EPS history for BioXcel Therapeutics from 2017 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-6,70ย โ‚ฌ24.03%
2022-5,41ย โ‚ฌ44.85%
2021-3,73ย โ‚ฌ7.65%
2020-3,47ย โ‚ฌ87.62%
2019-1,85ย โ‚ฌ51.88%
2018-1,22ย โ‚ฌ350.92%
2017-0,27ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-1,99ย โ‚ฌ-69.34%๐Ÿ‡บ๐Ÿ‡ธ USA